Sunday, January 21, 2018 1:42:49 PM
if you take a look at the news on this page from ACGX website
http://alliancecreativegroup.com/blog
you will get to see that Q 1 (2017) revenues were 5.1 million $
and Q 2 (2017)revenues were 4.7 million $ and
Q3 (2017) were 4.5 million $ revs and Q4 is coming our way and should gather a similar number placing the total year to around
18 -20 million $ in revenues !
it is going to be a record year revenues in ACGX existence and most importantly it will be a debt free company this year!
and this is will be the first time that the company will generate such numbers in a debt free status !!!
with 1.7 billion OS and 0.0015 price per share now the company is sitting at 2.55 million $ market cap !!!!
a company generating 18-20 million in revs should have a market cap in the 100 million $ range and not in the 2.55 million $ range !
and at a 100 million cap range the pps will be 0.06 cents +
ACGX is way undervalued pennystock and the upcoming news this year about its revenues and its debt free status are going to set the course of the price toward pennyland !!
ACGX price days at these levels are becoming counted !
the investment community is starting to realize what is going on here with ACGX and is going to give it fair value soon
direction pennies soon for ACGX
Recent ACGX News
- Alliance Creative Group (ACGX) Releases 2023 Annual Financial and Disclosure Report - PeopleVine's revenue increased by 100% in 2023 • InvestorsHub NewsWire • 04/01/2024 12:00:00 PM
- Alliance Creative Group (ACGX) Reports Third Quarter of 2023 Financials • InvestorsHub NewsWire • 11/15/2023 01:00:00 PM
- Alliance Creative Group (ACGX) Reports Second Quarter of 2023 Financials • InvestorsHub NewsWire • 08/14/2023 08:30:00 PM
- Alliance Creative Group (ACGX) Becomes an Equity Partner of the Coastal Spritz Brand • InvestorsHub NewsWire • 06/13/2023 12:00:00 PM
- Alliance Creative Group (ACGX) Reports First Quarter of 2023 Financials with Over $4,000,000 in assets • InvestorsHub NewsWire • 05/15/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM